MPX International Corp

PINK:MPXOF USA Drug Manufacturers - Specialty & Generic
Market Cap
$14.43K
Market Cap Rank
#44629 Global
#14119 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$0.59
About

MPX International Corporation, operates as a cannabis company in Canada and internationally. It offers cannabis products under HOLYWEED, beleaf, SALSUS, MPX labs, Canveda, SPARTAN WELLNESS, HIGH12, STRAIN REE, PENNIES, Kingsway, DAIZE, and alice brands. The company was founded in 2015 and is headquartered in Toronto, Canada.

MPX International Corp (MPXOF) - Net Assets

Latest net assets as of March 2022: $9.89 Million USD

Based on the latest financial reports, MPX International Corp (MPXOF) has net assets worth $9.89 Million USD as of March 2022.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($47.13 Million) and total liabilities ($37.24 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $9.89 Million
% of Total Assets 20.98%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility 98.04

MPX International Corp - Net Assets Trend (2016–2021)

This chart illustrates how MPX International Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for MPX International Corp (2016–2021)

The table below shows the annual net assets of MPX International Corp from 2016 to 2021.

Year Net Assets Change
2021-09-30 $22.85 Million -32.85%
2020-09-30 $34.02 Million -50.94%
2019-09-30 $69.34 Million +165.50%
2018-09-30 $26.12 Million +3927.04%
2017-09-30 $-682.40K +31.96%
2016-09-30 $-1.00 Million --

Equity Component Analysis

This analysis shows how different components contribute to MPX International Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 7313327200.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (September 2021)

Component Amount Percentage
Common Stock $66.40 Million 379.95%
Other Comprehensive Income $1.41 Million 8.07%
Other Components $22.80 Million 130.44%
Total Equity $17.48 Million 100.00%

MPX International Corp Competitors by Market Cap

The table below lists competitors of MPX International Corp ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in MPX International Corp's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2020 to 2021, total equity changed from 33,957,189 to 17,476,794, a change of -16,480,395 (-48.5%).
  • Net loss of 26,634,806 reduced equity.
  • New share issuances of 7,490,257 increased equity.
  • Other comprehensive income increased equity by 572,763.
  • Other factors increased equity by 2,091,391.

Equity Change Factors (2020 to 2021)

Factor Impact Contribution
Net Income $-26.63 Million -152.4%
Share Issuances $7.49 Million +42.86%
Other Comprehensive Income $572.76K +3.28%
Other Changes $2.09 Million +11.97%
Total Change $- -48.53%

Book Value vs Market Value Analysis

This analysis compares MPX International Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.00x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2018-09-30 $0.58 $0.00 x
2019-09-30 $0.97 $0.00 x
2020-09-30 $0.24 $0.00 x
2021-09-30 $0.12 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently MPX International Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -152.40%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -369.38%
  • • Asset Turnover: 0.14x
  • • Equity Multiplier: 2.90x
  • Recent ROE (-152.40%) is below the historical average (-49.14%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 0.00% 0.00% 0.00x 0.00x $-785.44K
2017 0.00% -8854.73% 0.03x 0.00x $-704.34K
2018 -8.06% -3266.35% 0.00x 1.04x $-4.72 Million
2019 -13.50% -589.27% 0.02x 1.11x $-16.32 Million
2020 -120.87% -1294.20% 0.06x 1.54x $-44.44 Million
2021 -152.40% -369.38% 0.14x 2.90x $-28.38 Million

Industry Comparison

This section compares MPX International Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
MPX International Corp (MPXOF) $9.89 Million 0.00% 3.77x $12.40K
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million